SCHEMBL6405060

SCHEMBL6405060

COC(=O)c1ccc(C(=O)NNC(=O)c2cc3cc(Cl)ccc3[nH]2)c(N)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.52
NHERF1 O14745 2/20 0.49
KDM4E B2RXH2 3/20 0.49
ALDH1A1 P00352 2/20 0.49
HPGD P15428 2/20 0.49
GLA P06280 1/20 0.49
GAA P10253 1/20 0.49
CASP1 P29466 1/20 0.49
CASP7 P55210 1/20 0.49
ATM Q13315 1/20 0.49
HSD17B10 Q99714 1/20 0.49
ABL1 P00519 1/20 0.48
PYGL P06737 1/20 0.47
FLT3 P36888 1/20 0.46
BCAT1 P54687 3/20 0.46
HRH4 Q9H3N8 2/20 0.46
HRH3 Q9Y5N1 1/20 0.46
LMNA P02545 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404418 0.88 NHERF1 (0.56) MAPTNHERF1PYGLBCAT1HRH4
SCHEMBL6401932 0.85 MAPT (0.65) MAPTNHERF1PYGLFLT3BCAT1
SCHEMBL6404677 0.84 BCAT1 (0.56) NHERF1PYGLBCAT1HRH4HRH3
SCHEMBL6402152 0.82 MEN1 (0.60) MAPTNHERF1PYGLBCAT1F7
Hydrochloric Acid SCHEMBL6399726 0.81 MEN1 (0.59) MAPTNHERF1PYGLBCAT1F7
SCHEMBL6399999 0.81 NHERF1 (0.63) NHERF1KDM4EPYGLBCAT1HDAC3
SCHEMBL6407127 0.81 NHERF1 (0.56) MAPTNHERF1PYGLBCAT1HRH4
SCHEMBL6400285 0.80 MEN1 (0.55) NHERF1BCAT1HRH4HRH3SMYD3
SCHEMBL6401115 0.79 MEN1 (0.55) MAPTNHERF1PYGLBCAT1F7
SCHEMBL6400936 0.78 BCAT1 (0.56) NHERF1PYGLBCAT1HRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US claimed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP claimed
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 MAPT 4405/4885NHERF1 332/4885KDM4E 1617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.